Literature DB >> 26599385

Subclinical gut inflammation in ankylosing spondylitis.

Francesco Ciccia1, Aroldo Rizzo, Giovanni Triolo.   

Abstract

PURPOSE OF REVIEW: Subclinical gut inflammation has been described in a significant proportion of patients with ankylosing spondylitis (AS), up to 10% of them developing it during the time of clinically overt inflammatory bowel disease. Histologic, immunologic, and intestinal microbiota alterations characterize the AS gut. RECENT
FINDINGS: Microbial dysbiosis as well as alterations of innate immune responses have been demonstrated in the gut of AS. Furthermore, a growing body of evidence suggests that the gut of AS patients may be actively involved in the pathogenesis of AS through the production of proinflammatory cytokines, such as IL-23p19, and the differentiation of potentially pathogenic innate lymphoid cells producing IL-22 and IL-17. Finally, a strong correlation between the presence of subclinical gut inflammation and the degree of spine inflammation have been also proved in AS.
SUMMARY: Subclinical gut inflammation and innate immune responses in AS may be considered a possible consequence of microbial dysbiosis. Relationships between cause and effect remain, however, to be answered.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26599385     DOI: 10.1097/BOR.0000000000000239

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  27 in total

Review 1.  Relationship between diet and ankylosing spondylitis: A systematic review.

Authors:  Tatiana V Macfarlane; Hadeel M Abbood; Ejaz Pathan; Katy Gordon; Juliane Hinz; Gary J Macfarlane
Journal:  Eur J Rheumatol       Date:  2017-10-25

Review 2.  Interleukin-9 and T helper type 9 cells in rheumatic diseases.

Authors:  F Ciccia; G Guggino; A Ferrante; P Cipriani; R Giacomelli; G Triolo
Journal:  Clin Exp Immunol       Date:  2016-08       Impact factor: 4.330

3.  Ribosomal PCR assay of excised intervertebral discs from patients undergoing single-level primary lumbar microdiscectomy.

Authors:  Todd F Alamin; Marcus Munoz; Alicia Zagel; Agnes Ith; Eugene Carragee; Ivan Cheng; Gaetano Scuderi; Indre Budvytiene; Niaz Banei
Journal:  Eur Spine J       Date:  2017-05-31       Impact factor: 3.134

4.  Association of methylation level and transcript level in TRAF5 gene with ankylosing spondylitis: a case-control study.

Authors:  Shanshan Xu; Xing Gao; Yubo Ma; Jixiang Deng; Shengqian Xu; Faming Pan
Journal:  Genes Immun       Date:  2021-05-21       Impact factor: 2.676

5.  Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.

Authors:  Andrea Levitova; Hana Hulejova; Maja Spiritovic; Karel Pavelka; Ladislav Senolt; Marketa Husakova
Journal:  Arthritis Res Ther       Date:  2016-11-25       Impact factor: 5.156

Review 6.  A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Lianjun Yang; Liping Wang; Xin Wang; Cory J Xian; Hai Lu
Journal:  Int J Mol Sci       Date:  2016-12-17       Impact factor: 5.923

7.  Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.

Authors:  Maja Skov Kragsnaes; Jens Kjeldsen; Hans Christian Horn; Heidi Lausten Munk; Finn Moeller Pedersen; Hanne Marie Holt; Jens Kristian Pedersen; Dorte Kinggaard Holm; Henning Glerup; Vibeke Andersen; Ulrich Fredberg; Karsten Kristiansen; Robin Christensen; Torkell Ellingsen
Journal:  BMJ Open       Date:  2018-04-27       Impact factor: 2.692

Review 8.  The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights.

Authors:  Zoya Qaiyum; Melissa Lim; Robert D Inman
Journal:  Semin Immunopathol       Date:  2021-02-24       Impact factor: 11.759

9.  Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study.

Authors:  Thomas Bazin; Katarzyna B Hooks; Thomas Barnetche; Marie-Elise Truchetet; Raphaël Enaud; Christophe Richez; Maxime Dougados; Christophe Hubert; Aurélien Barré; Macha Nikolski; Thierry Schaeverbeke
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

10.  Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis.

Authors:  Iulia Rahela Marcu; Dalia Dop; Vlad Padureanu; Stefan Adrian Niculescu; Rodica Padureanu; Carmen Elena Niculescu; Otilia Constantina Rogoveanu
Journal:  Medicina (Kaunas)       Date:  2020-05-29       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.